Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 533,474 | 192,870 | 204,524 | 193,627 | 183,643 |
| Marketable Securities | 29,885 | 29,960 | 38,950 | 40,685 | 43,512 |
| Receivables | 335,828 | 326,307 | 339,653 | 348,253 | 376,985 |
| Inventories | 377,594 | 369,041 | 375,616 | 383,266 | 382,684 |
| Income taxes - deferred | N/A | N/A | 41,408 | N/A | N/A |
| TOTAL | $1,397,835 | $1,049,922 | $1,093,941 | $1,083,446 | $1,119,782 |
| Non-Current Assets | |||||
| PPE Net | 302,836 | 294,611 | 300,732 | 293,128 | 290,737 |
| Intangibles | 532,197 | 519,161 | 550,410 | 525,410 | 569,120 |
| Other Non-Current Assets | 111,589 | 91,614 | 92,181 | 112,961 | 119,281 |
| TOTAL | $946,622 | $905,386 | $943,323 | $931,499 | $979,138 |
| Total Assets | $2,344,457 | $1,955,308 | $2,037,264 | $2,014,945 | $2,098,920 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 90,850 | 95,952 | 117,982 | 100,626 | 102,320 |
| Accrued Expenses | 104,267 | 91,621 | 119,420 | 107,502 | 105,069 |
| Other current liabilities | 100,759 | 98,013 | 98,290 | 97,074 | 98,238 |
| TOTAL | $383,609 | $355,879 | $418,034 | $385,814 | $408,087 |
| Non-Current Liabilities | |||||
| Long Term Debt | 738,454 | 444,209 | 445,979 | 446,378 | 440,687 |
| Other Non-Current Liabilities | 51,004 | 55,178 | 58,333 | 92,934 | 91,658 |
| TOTAL | $833,207 | $541,130 | $548,590 | $578,896 | $576,275 |
| Total Liabilities | $1,216,816 | $897,009 | $966,624 | $964,710 | $984,362 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,416 | 27,366 | 27,320 | 27,293 | 27,141 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 919,810 | 881,841 | 851,577 | 859,793 | 831,960 |
| Other shareholders' equity | 88,908 | 48,078 | 94,659 | 71,853 | 171,799 |
| TOTAL | $1,127,641 | $1,058,299 | $1,070,640 | $1,050,235 | $1,114,558 |
| Total Liabilities And Equity | $2,344,457 | $1,955,308 | $2,037,264 | $2,014,945 | $2,098,920 |